What is Harvard Apparatus Regenerative Technology Current Ratio?
Harvard Apparatus Regenerative TechnologyHRGN 33 Current Ratio is 0.53 as of Mar. 2026, which is 71% below its 10-year median of 1.84. GuruFocus rates HRGN with a GF Score™ of 33/100 and a GF Value™ of $5.34 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,985 Consumer Packaged Goods companies, Harvard Apparatus Regenerative Technology ranks worse than 94.11% on this metric.
Harvard Apparatus Regenerative Technology has a current ratio of 0.53. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Harvard Apparatus Regenerative Technology has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
HRGN's Current Ratio is ranked worse than 94.11% of 1985
companies
in the Consumer Packaged Goods industry
Industry Median: 1.73
vs HRGN: 0.53
Harvard Apparatus Regenerative Technology (OTCPK:HRGN) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Harvard Apparatus Regenerative Technology Current Ratio Related Terms
Harvard Apparatus Regenerative Technology Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Apparatus Regenerative Technology Current Ratio Chart
Harvard Apparatus Regenerative Technology Annual Data
HRGN vs DTEAF, STCB, JVA: Current Ratio Comparison
For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harvard Apparatus Regenerative Technology Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's Current Ratio distribution charts can be found below:
* The bar in red indicates where Harvard Apparatus Regenerative Technology's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Apparatus Regenerative Technology (HRGN) has a Current Ratio of 0.53 as of Mar. 2026. This is 71% below median its historical median of 1.84. Over the past decade, Harvard Apparatus Regenerative Technology's Current Ratio has ranged from 0.28 to 4.68. According to the industry distribution chart, Harvard Apparatus Regenerative Technology ranks #1868 out of 1985 companies in the Consumer Packaged Goods industry, placing it in the top 94.1%.
Is Harvard Apparatus Regenerative Technology's Current Ratio too high?
Harvard Apparatus Regenerative Technology's current Current Ratio of 0.53 is 71% below median its 10-year median of 1.84. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 4.68. The Consumer Packaged Goods industry median Current Ratio is 1.73. Harvard Apparatus Regenerative Technology's value of 0.53 is 69.4% below this industry median. Based on the distribution chart, Harvard Apparatus Regenerative Technology ranks #1868 out of 1985 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Current Ratio compare to DTEAF and STCB?
According to the Consumer Packaged Goods industry distribution chart, Harvard Apparatus Regenerative Technology ranks #1868 out of 1985 companies for Current Ratio. This places Harvard Apparatus Regenerative Technology in the lower half of its industry. The industry median Current Ratio is 1.73. Harvard Apparatus Regenerative Technology's value of 0.53 is 69.4% below this benchmark. Historically, Harvard Apparatus Regenerative Technology's own Current Ratio has ranged from 0.28 to 4.68 over the past decade. While the company's 10-year median is 1.84 vs. the industry median of 1.73, Harvard Apparatus Regenerative Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,985 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Harvard Apparatus Regenerative Technology's current Current Ratio of 0.53 is 69.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harvard Apparatus Regenerative Technology's current Current Ratio is 0.53, which is 71% below median its own 10-year median of 1.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology (HRGN) is currently considered Possible Value Trap. The stock's GF Value™ is $5.34, compared to a current price of $1.04 — trading 80.5% below its estimated fair value. The current Current Ratio is 0.53, which is 71% below median its 10-year median of 1.84 and 69.4% below the Consumer Packaged Goods industry median of 1.73. Harvard Apparatus Regenerative Technology's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Current Ratio is 0.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Harvard Apparatus Regenerative Technology (HRGN) Overvalued in 2026?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology stock appears to be undervalued.
The current stock price of $1.04 is trading 80.5% below its estimated GF Value™ of $5.34.
GuruFocus considers Harvard Apparatus Regenerative Technology to be Possible Value Trap.
Key valuation signals for HRGN:
Current Ratio: 0.53 (71% below median its 10-year median of 1.84)
GF Value™: $5.34 vs. price of $1.04 (80.5% below fair value)
Industry Position: 69.4% below the Consumer Packaged Goods median (#1868 of 1985)
No single metric tells the full story. See the HRGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Harvard Apparatus Regenerative Technology Business Description
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
33GF Score
Get the complete analysis for HRGN
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HRGN has been successfully added to your 
